This inventor holds 1 USPTO granted patent. Top assignee: Usv Private Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Mandar Ravindra Maduskar: Innovator in Peptide Chemistry
Introduction
Mandar Ravindra Maduskar is a notable inventor based in Mumbai, India. He has made significant contributions to the field of peptide chemistry, particularly through his innovative processes for peptide synthesis. His work is characterized by a focus on efficiency, environmental sustainability, and cost-effectiveness.
Latest Patents
Maduskar holds a patent for a solid phase Fmoc chemistry process to prepare peptides. This invention relates to an improved method for synthesizing N-(aminoiminomethyl)-N-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1→6)-disulfide. The process involves assembling a peptide chain on a solid support, capping free amino groups, and utilizing various chemical techniques to obtain the final peptide product. This method is noted for being simple, environmentally friendly, and more cost-effective compared to traditional approaches.
Career Highlights
Maduskar is currently employed at USV Private Limited, where he continues to advance his research in peptide synthesis. His work has garnered attention for its innovative approach and practical applications in the pharmaceutical industry.
Collaborations
He has collaborated with notable colleagues, including Divya Lal Saksena and Chandrakesan Muralidharan, contributing to a dynamic research environment that fosters innovation and development in peptide chemistry.
Conclusion
Mandar Ravindra Maduskar's contributions to peptide chemistry exemplify the spirit of innovation in the field. His patented processes not only enhance the efficiency of peptide synthesis but also promote environmentally sustainable practices. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
